Literature DB >> 25858564

Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH.

I Bodó1, J Eikenboom2, R Montgomery3, J Patzke4, R Schneppenheim5, J Di Paola6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25858564      PMCID： PMC5576173          DOI： 10.1111/jth.12964

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  56 in total

1.  Discrimination of von Willebrands disease (VWD) subtypes: direct comparison of von Willebrand factor:collagen binding assay (VWF:CBA) with monoclonal antibody (MAB) based VWF-capture systems.

Authors:  E J Favaloro; A Henniker; D Facey; M Hertzberg
Journal:  Thromb Haemost       Date:  2000-10       Impact factor: 5.249

2.  The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization.

Authors:  M Laffan; S A Brown; P W Collins; A M Cumming; F G H Hill; D Keeling; I R Peake; K J Pasi
Journal:  Haemophilia       Date:  2004-05       Impact factor: 4.287

3.  Evaluation of an automated platelet-based assay of ristocetin cofactor activity.

Authors:  A S Lawrie; I J Mackie; S J Machin; F Peyvandi
Journal:  Haemophilia       Date:  2010-11-11       Impact factor: 4.287

4.  Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.

Authors:  J P Allain; H A Cooper; R H Wagner; K M Brinkhous
Journal:  J Lab Clin Med       Date:  1975-02

Review 5.  Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von Willebrand factor assays.

Authors:  Emmanuel J Favaloro
Journal:  Blood Coagul Fibrinolysis       Date:  2011-10       Impact factor: 1.276

6.  Laboratory diagnosis of von Willebrand disease.

Authors:  J Patzke; R Schneppenheim
Journal:  Hamostaseologie       Date:  2010-11       Impact factor: 1.778

7.  Ristocetin--a new tool in the investigation of platelet aggregation.

Authors:  M A Howard; B G Firkin
Journal:  Thromb Diath Haemorrh       Date:  1971-10-31

8.  Determination of von Willebrand factor activity: evaluation of the HaemosIL assay in comparison with established procedures.

Authors:  Christoph Sucker; Beate Senft; Rüdiger E Scharf; Rainer B Zotz
Journal:  Clin Appl Thromb Hemost       Date:  2006-07       Impact factor: 2.389

9.  A comparative evaluation of a new automated assay for von Willebrand factor activity.

Authors:  A S Lawrie; F Stufano; M T Canciani; I J Mackie; S J Machin; F Peyvandi
Journal:  Haemophilia       Date:  2012-12-04       Impact factor: 4.287

10.  Validation of a new panel of automated chemiluminescence assays for von Willebrand factor antigen and activity in the screening for von Willebrand disease.

Authors:  C J Verfaillie; E De Witte; K M J Devreese
Journal:  Int J Lab Hematol       Date:  2013-04-03       Impact factor: 2.877
View more
  29 in total

1.  Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.

Authors:  Veronica H Flood; Pamela A Christopherson; Joan Cox Gill; Kenneth D Friedman; Sandra L Haberichter; Daniel B Bellissimo; Rupa A Udani; Mahua Dasgupta; Raymond G Hoffmann; Margaret V Ragni; Amy D Shapiro; Jeanne M Lusher; Steven R Lentz; Thomas C Abshire; Cindy Leissinger; W Keith Hoots; Marilyn J Manco-Johnson; Ralph A Gruppo; Lisa N Boggio; Kate T Montgomery; Anne C Goodeve; Paula D James; David Lillicrap; Ian R Peake; Robert R Montgomery
Journal:  Blood       Date:  2016-02-09       Impact factor: 22.113

Review 2.  Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis.

Authors:  Piercarla Schinco; Giancarlo Castaman; Antonio Coppola; Dorina Cultrera; Cosimo Ettorre; Anna C Giuffrida; Emanuela Marchesini; Renato Marino; Marta Milan; Claudio Molinari; Simona M Siboni; Ezio Zanon; Augusto B Federici
Journal:  Blood Transfus       Date:  2017-05-26       Impact factor: 3.443

3.  Rapid discrimination of the phenotypic variants of von Willebrand disease.

Authors:  Jonathan C Roberts; Patti A Morateck; Pamela A Christopherson; Ke Yan; Raymond G Hoffmann; Joan Cox Gill; Robert R Montgomery
Journal:  Blood       Date:  2016-02-25       Impact factor: 22.113

4.  The role of genetics in the pathogenesis and diagnosis of type 1 Von Willebrand disease.

Authors:  Veronica H Flood; Jessica Garcia; Sandra L Haberichter
Journal:  Curr Opin Hematol       Date:  2019-09       Impact factor: 3.284

5.  Von Willebrand disease in the United States: perspective from the Zimmerman program.

Authors:  Veronica H Flood; Thomas C Abshire; Pamela A Christopherson; Kenneth D Friedman; Joan Cox Gill; Robert R Montgomery; Sandra L Haberichter
Journal:  Ann Blood       Date:  2018-01-26

6.  Establishment of an International Reference Reagent for standardization of von Willebrand factor binding to recombinant glycoprotein Ib (VWF:GPIbM and VWF:GPIbR): Official Communication of the SSC.

Authors:  Anthony R Hubbard; Sandra L Haberichter
Journal:  J Thromb Haemost       Date:  2019-05-17       Impact factor: 5.824

7.  New advances in the diagnosis of von Willebrand disease.

Authors:  Ruchika Sharma; Sandra L Haberichter
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

8.  Comparison of von Willebrand factor platelet-binding activity assays: ELISA overreads type 2B with loss of HMW multimers.

Authors:  Attila Szederjesi; Luciano Baronciani; Ulrich Budde; Giancarlo Castaman; Paola Colpani; Andrew S Lawrie; Yuan Liu; Robert Montgomery; Flora Peyvandi; Reinhard Schneppenheim; Jürgen Patzke; Imre Bodó
Journal:  J Thromb Haemost       Date:  2020-08-27       Impact factor: 5.824

9.  Evaluation of a microfluidic flow assay to screen for von Willebrand disease and low von Willebrand factor levels.

Authors:  M Lehmann; K Ashworth; M Manco-Johnson; J Di Paola; K B Neeves; C J Ng
Journal:  J Thromb Haemost       Date:  2017-11-23       Impact factor: 5.824

Review 10.  New developments in von Willebrand disease.

Authors:  Helen Fogarty; Dearbhla Doherty; James S O'Donnell
Journal:  Br J Haematol       Date:  2020-05-12       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.